Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UBS Maintains Neutral on Ambev, Raises Price Target to $2.7

Author: Benzinga Newsdesk | June 04, 2025 08:52am
UBS analyst Rodrigo Alcantara maintains Ambev (NYSE:ABEV) with a Neutral and raises the price target from $2.6 to $2.7.

Posted In: ABEV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist